| HGNC Family | Non-coding RNAs |
| Name | microRNA 134 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMiR‑134 is a brain‐enriched microRNA that plays a pivotal role in neural development and synaptic plasticity. In neurons, it is enriched in the synapto‐dendritic compartment where it negatively regulates dendritic spine size by inhibiting the translation of specific targets such as Limk1, thereby fine‐tuning excitatory synaptic transmission and contributing to proper synapse development and maturation. Moreover, dynamic changes in miR‑134 levels have been associated with neurological disorders – its upregulation has been observed in models of status epilepticus where silencing reduces seizure susceptibility, while altered circulating levels correlate with the severity of manic episodes in bipolar disorder, suggesting its promise as a biomarker and therapeutic target in neuropsychiatric conditions."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn diverse malignancies, miR‑134 exerts context‐dependent roles that influence tumorigenesis, metastasis, and chemoresistance. In several cancers – including breast, non‑small cell lung, head and neck, glioblastoma, endometrial, renal, gastric, and colorectal carcinomas – miR‑134 functions largely as a tumor suppressor by targeting critical oncogenes such as CCND1, EGFR, FOXM1, STAT5B, Hsp90, WWOX, Nanog, ITGB1, KRAS, and GOLPH3. By dampening the expression of these targets, miR‑134 suppresses cellular proliferation, migration and invasion while promoting apoptosis. Notably, in some settings—such as certain oral squamous cell and ovarian carcinomas—its aberrant expression is associated with enhanced oncogenicity and drug resistance, underscoring its potential both as a prognostic biomarker and as a candidate for miRNA‐based therapeutic intervention."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "4", "end_ref": "32"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its roles in the nervous system and cancer, miR‑134 is emerging as an important modulator in cardiovascular, metabolic, and developmental processes. Altered circulating levels of miR‑134 have been linked to acute myocardial infarction, atherosclerosis, and even serve as early indicators in conditions such as gestational diabetes. Furthermore, miR‑134 modulates processes such as lung septation, angiogenesis, and the proliferation of cardiomyocyte progenitor cells—underscoring its involvement in cardiac development and diabetic vascular dysfunction. Its dysregulation has also been implicated in inflammatory disorders, exemplified by studies in adult‑onset Still’s disease, thereby highlighting the diverse and multifunctional nature of miR‑134 in both health and disease."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "33", "end_ref": "41"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Gerhard M Schratt, Fabian Tuebing, Elizabeth A Nigh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A brain-specific microRNA regulates dendritic spine development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature04367"}], "href": "https://doi.org/10.1038/nature04367"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16421561"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16421561"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Eva M Jimenez-Mateos, Tobias Engel, Paula Merino-Serrais, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm.2834"}], "href": "https://doi.org/10.1038/nm.2834"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22683779"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22683779"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Han Rong, Tie Bang Liu, Kong Jun Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-134 plasma levels before and after treatment for bipolar mania."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Psychiatr Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jpsychires.2010.04.028"}], "href": "https://doi.org/10.1016/j.jpsychires.2010.04.028"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20546789"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20546789"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Keith O'Brien, Michelle C Lowry, Claire Corcoran, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.5192"}], "href": "https://doi.org/10.18632/oncotarget.5192"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26416415"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26416415"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Kazuhiro Kitamura, Masahiro Seike, Tetsuya Okano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Ther (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1535-7163.MCT-13-0448"}], "href": "https://doi.org/10.1158/1535-7163.MCT-13-0448"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24258346"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24258346"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Jipeng Li, Yiping Wang, Jianping Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2012.09.016"}], "href": "https://doi.org/10.1016/j.febslet.2012.09.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23010597"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23010597"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Carolina Salazar, Rahul Nagadia, Pratibala Pandit, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel saliva-based microRNA biomarker panel to detect head and neck cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Oncol (Dordr) (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13402-014-0188-2"}], "href": "https://doi.org/10.1007/s13402-014-0188-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25156495"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25156495"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Chung-Ji Liu, Wilma Grace Shen, Shih-Yuan Peng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.28358"}], "href": "https://doi.org/10.1002/ijc.28358"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23824713"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23824713"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Cheng-Cao Sun, Shu-Jun Li, De-Jia Li "}, {"type": "b", "children": [{"type": "t", "text": "Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.8482"}], "href": "https://doi.org/10.18632/oncotarget.8482"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27166267"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27166267"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Chao Shi Niu, Yang Yang, Chuan-Dong Cheng "}, {"type": "b", "children": [{"type": "t", "text": "MiR-134 regulates the proliferation and invasion of glioblastoma cells by reducing Nanog expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo.2013.1844"}], "href": "https://doi.org/10.3892/ijo.2013.1844"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23467648"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23467648"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Ruopeng Zha, Weijie Guo, Zhenfeng Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0087665"}], "href": "https://doi.org/10.1371/journal.pone.0087665"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24498348"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24498348"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Y Zhang, J Kim, A C Mueller, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cdd.2013.196"}], "href": "https://doi.org/10.1038/cdd.2013.196"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24440911"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24440911"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Yongtao Gao, Te Liu, Yongyi Huang "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2014.12.002"}], "href": "https://doi.org/10.1016/j.febslet.2014.12.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25528443"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25528443"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Yiyang Liu, Mingcong Zhang, Jian Qian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "DNA Cell Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/dna.2014.2629"}], "href": "https://doi.org/10.1089/dna.2014.2629"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25811077"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25811077"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Qin Qin, Furong Wei, Jianbo Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-134 inhibits non-small cell lung cancer growth by targeting the epidermal growth factor receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.12889"}], "href": "https://doi.org/10.1111/jcmm.12889"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27241841"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27241841"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Yejun Liu, Zezhang Tao, Jining Qu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA PCAT7 regulates ELF2 signaling through inhibition of miR-134-5p in nasopharyngeal carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2017.07.093"}], "href": "https://doi.org/10.1016/j.bbrc.2017.07.093"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28728844"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28728844"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Shih-Yuan Peng, Hsi-Feng Tu, Cheng-Chieh Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-134 targets PDCD7 to reduce E-cadherin expression and enhance oral cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.31638"}], "href": "https://doi.org/10.1002/ijc.31638"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29971778"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29971778"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Qin Qin, Furong Wei, Jianbo Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-134 suppresses the migration and invasion of non‑small cell lung cancer by targeting ITGB1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2017.5350"}], "href": "https://doi.org/10.3892/or.2017.5350"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28075475"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28075475"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Jianmin Wu, Yimin Sun, Pei-Ying Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Fra-1-miR-134-SDS22 feedback loop amplifies ERK/JNK signaling and reduces chemosensitivity in ovarian cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2016.289"}], "href": "https://doi.org/10.1038/cddis.2016.289"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27685628"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27685628"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Ting Shuang, Min Wang, Cong Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Down-regulated expression of miR-134 contributes to paclitaxel resistance in human ovarian cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2015.08.047"}], "href": "https://doi.org/10.1016/j.febslet.2015.08.047"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26363097"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26363097"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Sherien M El-Daly, Mohammed L Abba, Nitin Patil, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miRs-134 and -370 function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signalling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep24720"}], "href": "https://doi.org/10.1038/srep24720"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27095166"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27095166"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Maria Leontariti, Margaritis Avgeris, Martha-Spyridoula Katsarou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating miR-146a and miR-134 in predicting drug-resistant epilepsy in patients with focal impaired awareness seizures."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Epilepsia (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/epi.16502"}], "href": "https://doi.org/10.1111/epi.16502"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32314378"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32314378"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Yongpeng Wei, Zhuo Wang, Yi Zong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MFI2-AS1 promotes HCC progression and metastasis by acting as a competing endogenous RNA of miR-134 to upregulate FOXM1 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2020.109890"}], "href": "https://doi.org/10.1016/j.biopha.2020.109890"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32106369"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32106369"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Yanqi Liu, Yanhong Sun, Aizhen Zhao "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-134 suppresses cell proliferation in gastric cancer cells via targeting of GOLPH3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2017.5488"}], "href": "https://doi.org/10.3892/or.2017.5488"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28260021"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28260021"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Yong-Mei Zhou, Yi-Lin Yao, Wei Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biomark (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3233/CBM-191362"}], "href": "https://doi.org/10.3233/CBM-191362"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32568182"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32568182"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Tianjun Chen, Fei Gao, Sifang Feng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-134 regulates lung cancer cell H69 growth and apoptosis by targeting WWOX gene and suppressing the ERK1/2 signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2015.07.021"}], "href": "https://doi.org/10.1016/j.bbrc.2015.07.021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26166818"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26166818"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Li Jiang, Yong Zhang, Bo Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.14883"}], "href": "https://doi.org/10.1111/cas.14883"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33728743"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33728743"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "F Mirzadeh Azad, P Naeli, M Malakootian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Two lung development-related microRNAs, miR-134 and miR-187, are differentially expressed in lung tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2015.11.040"}], "href": "https://doi.org/10.1016/j.gene.2015.11.040"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26642897"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26642897"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Yuguang Zhao, Dong Pang, Cui Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-134 modulates glioma cell U251 proliferation and invasion by targeting KRAS and suppressing the ERK pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-016-5027-9"}], "href": "https://doi.org/10.1007/s13277-016-5027-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27012554"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27012554"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Qiang Zhang, Jiaqi Wu, Xiangfeng Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcription factor ELK1 accelerates aerobic glycolysis to enhance osteosarcoma chemoresistance through miR-134/PTBP1 signaling cascade."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.202538"}], "href": "https://doi.org/10.18632/aging.202538"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33621196"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33621196"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Chao Yang, Geng Zhang, Yanshou Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exosome miR-134-5p restrains breast cancer progression via regulating PI3K/AKT pathway by targeting ARHGAP1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Obstet Gynaecol Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jog.14983"}], "href": "https://doi.org/10.1111/jog.14983"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34378285"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34378285"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "C Xi, N-Y Ye, Y-B Wang "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA LINC01278 accelerates colorectal cancer progression via miR-134-5p/KDM2A axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202010_23405"}], "href": "https://doi.org/10.26355/eurrev_202010_23405"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33155208"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33155208"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Ke-Jing Wang, Xin Zhao, Yu-Zhou Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating MiR-19b-3p, MiR-134-5p and MiR-186-5p are Promising Novel Biomarkers for Early Diagnosis of Acute Myocardial Infarction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000443053"}], "href": "https://doi.org/10.1159/000443053"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26939053"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26939053"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Fucheng He, Pin Lv, Xue Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Predictive value of circulating miR-328 and miR-134 for acute myocardial infarction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biochem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11010-014-2089-0"}], "href": "https://doi.org/10.1007/s11010-014-2089-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24833470"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24833470"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Junjie Xiao, Zhi-Cheng Jing, Patrick T Ellinor, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Transl Med (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1479-5876-9-159"}], "href": "https://doi.org/10.1186/1479-5876-9-159"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21943159"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21943159"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Jingxia Zhou, Lin Chen, Bocan Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased serum exosomal miR-134 expression in the acute ischemic stroke patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Neurol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12883-018-1196-z"}], "href": "https://doi.org/10.1186/s12883-018-1196-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30514242"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30514242"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Gang Lan, Wei Xie, Liang Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-134 actives lipoprotein lipase-mediated lipid accumulation and inflammatory response by targeting angiopoietin-like 4 in THP-1 macrophages."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2015.10.158"}], "href": "https://doi.org/10.1016/j.bbrc.2015.10.158"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26546816"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26546816"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Xiaoying Zhang, Hui Wang, Sheng Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-134 functions as a regulator of cell proliferation, apoptosis, and migration involving lung septation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "In Vitro Cell Dev Biol Anim (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11626-012-9482-3"}], "href": "https://doi.org/10.1007/s11626-012-9482-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22259016"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22259016"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Hsei-Wei Wang, Shu-Han Su, Yen-Li Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-134 Contributes to Glucose-Induced Endothelial Cell Dysfunction and This Effect Can Be Reversed by Far-Infrared Irradiation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0147067"}], "href": "https://doi.org/10.1371/journal.pone.0147067"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26799933"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26799933"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Ya-Han Wu, Hong Zhao, Li-Ping Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-134 Modulates the Proliferation of Human Cardiomyocyte Progenitor Cells by Targeting Meis2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms161025199"}], "href": "https://doi.org/10.3390/ijms161025199"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26512644"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26512644"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Tsai-Ling Liao, Yi-Ming Chen, Chia-Wei Hsieh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upregulation of circulating microRNA-134 in adult-onset Still's disease and its use as potential biomarker."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-017-04086-w"}], "href": "https://doi.org/10.1038/s41598-017-04086-w"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28646209"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28646209"}]}]}]}
|
| Synonyms | MIRN134, MIR-134 |
| NCBI Gene ID | 406924 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR134 has 434 functional associations with biological entities spanning 6 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 17 datasets.
Click the + buttons to view associations for MIR134 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR134 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR134 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MIR134 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR134 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| CTD Gene-Disease Associations | diseases associated with MIR134 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR134 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR134 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR134 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MIR134 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MIR134 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MIR134 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MIR134 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MIR134 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR134 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of MIR134 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR134 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR134 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |